{
  "input_name": "Moderna",
  "canonical": {
    "resolved_name": "Moderna, Inc.",
    "ticker": "MRNA",
    "cik": 1682852.0,
    "website": "https://www.modernatx.com",
    "name_variants": [
      "Moderna, Inc.",
      "Moderna,"
    ]
  },
  "pipeline": {
    "candidates": [
      {
        "nct": "NCT04266249",
        "status": "ACTIVE_NOT_RECRUITING",
        "phase": "phase2",
        "condition": "Anatomic Stage II Breast Cancer AJCC v8",
        "intervention": "Docetaxel",
        "source_url": "https://clinicaltrials.gov/study/NCT04266249",
        "fetched": "2025-09-24T13:40:25.615281",
        "evidence_snippet": "CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy | Condition: Anatomic Stage II Breast",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT06143046",
        "status": "ACTIVE_NOT_RECRUITING",
        "phase": "phase2",
        "condition": "Respiratory Syncytial Virus",
        "intervention": "mRNA-1345",
        "source_url": "https://clinicaltrials.gov/study/NCT06143046",
        "fetched": "2025-09-24T13:40:25.615281",
        "evidence_snippet": "A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers | Condition: Respirator",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT05119855",
        "status": "COMPLETED",
        "phase": "phase3",
        "condition": "Papillomavirus Infections",
        "intervention": "9vHPV Vaccine",
        "source_url": "https://clinicaltrials.gov/study/NCT05119855",
        "fetched": "2025-09-24T13:40:25.615281",
        "evidence_snippet": "Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Res",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT03253848",
        "status": "ACTIVE_NOT_RECRUITING",
        "phase": "unknown",
        "condition": "Acute Promyelocytic Leukemia With PML-RARA",
        "intervention": "Simplified Patient Care Strategy",
        "source_url": "https://clinicaltrials.gov/study/NCT03253848",
        "fetched": "2025-09-24T13:40:25.616281",
        "evidence_snippet": "Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia | Condition: Acute Promyelocytic Leukemia Wit",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT05398796",
        "status": "COMPLETED",
        "phase": "phase1",
        "condition": "Nipah Virus Infection",
        "intervention": "mRNA -1215",
        "source_url": "https://clinicaltrials.gov/study/NCT05398796",
        "fetched": "2025-09-24T13:40:25.616281",
        "evidence_snippet": "Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Heal",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT04297917",
        "status": "COMPLETED",
        "phase": "phase1",
        "condition": "Hepatitis B",
        "intervention": "ChAdOx1-HBV",
        "source_url": "https://clinicaltrials.gov/study/NCT04297917",
        "fetched": "2025-09-24T13:40:25.616281",
        "evidence_snippet": "First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection | Condition: Hepatitis B | Intervention: ChAd",
        "matched_variant": "Moderna, Inc."
      },
      {
        "nct": "NCT04934111",
        "status": "UNKNOWN",
        "phase": "phase1",
        "condition": "COVID-19",
        "intervention": "LNP-nCOV saRNA-02 Vaccine",
        "source_url": "https://clinicaltrials.gov/study/NCT04934111",
        "fetched": "2025-09-24T13:40:25.616281",
        "evidence_snippet": "Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19 | Condition: COVID-19 | Intervention: LNP-n",
        "matched_variant": "Moderna, Inc."
      }
    ],
    "counts_by_phase": {
      "phase2": 2,
      "phase3": 1,
      "unknown": 1,
      "phase1": 3
    }
  },
  "financial": {
    "public": true,
    "filings": [
      {
        "form": "10-K",
        "filing_date": "0001682852-25-000022",
        "file_path": "C:\\Users\\Pc\\Desktop\\Business School Work\\sec-edgar-filings\\MRNA\\10-K\\0001682852-25-000022\\full-submission.txt",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000022/index.html",
        "fetched": "2025-09-24T13:40:25.871249"
      },
      {
        "form": "10-K",
        "filing_date": "0001682852-24-000015",
        "file_path": "C:\\Users\\Pc\\Desktop\\Business School Work\\sec-edgar-filings\\MRNA\\10-K\\0001682852-24-000015\\full-submission.txt",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-24-000015/index.html",
        "fetched": "2025-09-24T13:40:25.871249"
      },
      {
        "form": "10-Q",
        "filing_date": "0001682852-25-000044",
        "file_path": "C:\\Users\\Pc\\Desktop\\Business School Work\\sec-edgar-filings\\MRNA\\10-Q\\0001682852-25-000044\\full-submission.txt",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000044/index.html",
        "fetched": "2025-09-24T13:40:26.096753"
      },
      {
        "form": "10-Q",
        "filing_date": "0001682852-25-000034",
        "file_path": "C:\\Users\\Pc\\Desktop\\Business School Work\\sec-edgar-filings\\MRNA\\10-Q\\0001682852-25-000034\\full-submission.txt",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000034/index.html",
        "fetched": "2025-09-24T13:40:26.096753"
      }
    ],
    "provenance": [
      {
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000022/index.html",
        "source_type": "edgar",
        "fetched": "2025-09-24T13:40:25.871249",
        "evidence_snippet": "10-K filing on 0001682852-25-000022"
      },
      {
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-24-000015/index.html",
        "source_type": "edgar",
        "fetched": "2025-09-24T13:40:25.871249",
        "evidence_snippet": "10-K filing on 0001682852-24-000015"
      },
      {
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000044/index.html",
        "source_type": "edgar",
        "fetched": "2025-09-24T13:40:26.096753",
        "evidence_snippet": "10-Q filing on 0001682852-25-000044"
      },
      {
        "source_url": "https://www.sec.gov/Archives/edgar/data/1682852.0/0001682852-25-000034/index.html",
        "source_type": "edgar",
        "fetched": "2025-09-24T13:40:26.096753",
        "evidence_snippet": "10-Q filing on 0001682852-25-000034"
      }
    ]
  },
  "news": []
}